About the Company
mri-guided adaptive radiotherapy viewray®, inc. (nasdaq:vray), designs, manufactures, and markets the mridian® radiation therapy system to address the key limitations of existing external-beam radiation therapy technologies. mridian employs mri-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. mridian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription as needed. viewray believes this combination of enhanced visualization, on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients. at viewray, our vision is clear. we’re dedicated to giving doctors new and better ways to treat cancer with radiation therapy. we’re an entrepreneurial company with big ambitions, unlimited potential and a passion for improving
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VRAY News
ViewRay Inc VRAYQ
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
ViewRay, Inc. (VRAY)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
ViewRay: Q1 Earnings Insights
ViewRay (NASDAQ:VRAY) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM. Here's what investors need to know about the announcement. ViewRay reported in-line EPS of $-0.16 ...
International Game Technology To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Ventas shares rose 0.7% to $47.35 in pre-market trading. B. Riley Securities lowered ViewRay, Inc. (NASDAQ: VRAY) price target from $4 to $1. B. Riley Securities analyst Justin Walsh downgraded ...
ViewRay, Inc. (VRAY) stock price, news, quote & history – Yahoo Finance
ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"). Nasdaq has ...
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
Etsy Inc.
1 Day ETSY -0.46% DJIA 0.67% S&P 500 0.87% Retail/Wholesale 0.37% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...
‘Food, Inc. 2’ Review: A Second Course
Share full article “Food, Inc. 2,” directed by Robert Kenner and Melissa Robledo, begins by describing how the last few years have shown the risks of letting a handful of mega-suppliers ...
UnitedHealth Group Incorporated
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth ...
ViewRay, Inc. (VRAY)
ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"). Nasdaq has ...
ViewRay, Inc. (VRAY) stock price, news, quote & history – Yahoo Finance
The latest analyst coverage could presage a bad day for ViewRay, Inc. ( NASDAQ:VRAY ), with the analysts making... Simply Wall St. ViewRay, Inc. ( NASDAQ:VRAY ) shareholders that were waiting for ...
ViewRay, Inc. (VRAYQ)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...